Agios Pharm (AGIO) Misses Q2 EPS by 13c

Agios Pharm (NASDAQ: AGIO) reported Q2 EPS of ($0.54), $0.13 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $8.41 million versus the consensus estimate of $11 million.

For earnings history and earnings-related data on Agios Pharm (AGIO) click here.

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• KKR Real Estate Finance Trust (KREF) Tops Q1 EPS by 4c
• Artisan Partners Asset Management (APAM) Misses Q1 EPS by 1c